Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle.
Increased interest in development of combined gene therapy emerges from results of recent clinical trials that indicate good safety yet unexpected low efficacy of "single-gene" administration. Multiple studies showed that vascular endothelial growth factor 165 aminoacid form (VEGF165) and...
Guardado en:
Autores principales: | Pavel Makarevich, Zoya Tsokolaeva, Alexander Shevelev, Igor Rybalkin, Evgeny Shevchenko, Irina Beloglazova, Tatyana Vlasik, Vsevolod Tkachuk, Yelena Parfyonova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ccb99f37a0ce4bbca79c397bebfc1c9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.
por: Antti Siltanen, et al.
Publicado: (2011) -
A Fluorescent Aptasensor Based on Assembled G-Quadruplex and Thioflavin T for the Detection of Biomarker VEGF165
por: Xin Zheng, et al.
Publicado: (2021) -
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
por: Tianrun Liu, et al.
Publicado: (2018) -
Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
por: Amber N. Stratman, et al.
Publicado: (2020) -
Endothelial Semaphorin 3fb regulates Vegf pathway-mediated angiogenic sprouting.
por: Charlene Watterston, et al.
Publicado: (2021)